NEW YORK (GenomeWeb News) – German analytical instrument firm Analytik Jena today announced it signed a contract to acquire life science imaging company UVP for an undisclosed price.

The deal is anticipated to close April 5, and, in addition to acquiring UVP, Analytik Jena will purchase the Upland, Calif.-based company's wholly owned subsidiary Ultra-Violet Products, headquartered in Cambridge, UK.

The deal launches Analytik Jena into the US market, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This Week in Nucleic Acids Research: Researchers describe a new method to find large-scale structural variants in cancer genomes, a glimpse at an approach for profiling miRNAs in tumor samples from TCGA, and more.

Intellia Therapeutics has raised $70 million, becoming the latest firm leveraging the gene editing technology to haul in a gob of cash.

Now going beyond reporting fetal aneuploidies, NIPTs may be providing too much information that may be useless, some doctors and genetic counselor say.

A group of organizations in the UK say that there needs to be discussions about the use of technologies such as CRISPR/Cas-9 for human germline editing.